Product Information
NORA-BE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0943 per EA under NDC 52544062928. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.35 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544062928
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017060On Market Since
5/12/2005
Pharmacological Classes
Price Statistics
The NADAC for NORA-BE TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 85.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.6358 (Dec 10, 2014) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.2140 |
| Average price | $0.2650 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORA-BE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORA-BE TABLET, manufactured by Actavis Pharma, Inc., is $0.0943 per EA (NDC 52544062928), effective Jun 24, 2026.
How has the price of NORA-BE TABLET changed over time?
Over the history we have for it, the NADAC for NORA-BE TABLET has declined 85.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORA-BE TABLET?
Since Nov 28, 2013, the NADAC for NORA-BE TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.6358 (Dec 10, 2014), with a median of $0.2140 per EA.
Are there cheaper alternatives to NORA-BE TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as NORA-BE TABLET, but none are currently priced below it.
Who manufactures NORA-BE TABLET?
NORA-BE TABLET (NDC 52544062928) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification